What is the INTERCEPT® Blood System, pathogen reduction system?
The INTERCEPT Blood System inactivates a broad spectrum of viruses, gram-positive and gram-negative bacteria, spirochetes, parasites and leukocytes. INTERCEPT is intended to reduce the risk of transfusion-transmitted infection (TTI) in platelet and plasma components. T-cells are also reduced to a level that potentially lowers the risk of transfusion-associated graft-versus-host disease (TA-GVHD) in platelet components.
How INTERCEPT works
Targeting DNA and RNA to prevent pathogen proliferation.
The INTERCEPT Blood System for Platelets lowers the risk of microbial contamination in blood components, thus reducing TTI and sepsis risk.